ArticleScientific reports2026
Explainable deep learning-based lung cancer diagnosis using clinically-guided local interpretable model-agnostic explanations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, highlighting the urgent need for accurate and interpretable diagnostic tools. While deep learning (DL) models have achieved strong results in medical image classification, their opaque decision-making process remains a barrier to clinical adoption. This study proposes an adaptive superpixel perturbation-based local interpretable model-agnostic explanations (ASP-LIME), a novel explanation framework designed to generate faithful and localized interpretations of DL predictions, providing insights into the model's decision-making process. The proposed approach improves upon the original local interpretable model-agnostic explanations method by introducing adaptive superpixel segmentation, stratified perturbation strategies, lung region masking, and post-processing enhancements tailored for medical imaging. The proposed framework is applied to a lung cancer classification task using a custom-designed convolutional neural network, MedDeepNet, as the predictive model. Experimental results on a publicly available lung image dataset demonstrate that MedDeepNet achieves 99.84% accuracy, 99.66% recall, 99.82% precision, 99.74% specificity, and a 99.74% F1-score. ASP-LIME produces high-fidelity explanations with strong localization to pathological regions, achieving scores of 0.0300 for deletion, 0.9622 for insertion, and 0.9661 for Area Between Perturbation Curves (ABPC), surpassing typical benchmarks for interpretability methods. The findings demonstrate that the proposed framework offers consistent and interpretable explanations that enhance understanding of model decisions in medical imaging applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.